The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.
Castagnetti, Fausto *,1; Gugliotta, Gabriele 1; Breccia, Massimo 2; Iurlo, Alessandra 3; Levato, Luciano 4; Albano, Francesco 5; Vigneri, Paolo 6; Abruzzese, Elisabetta 7; Rossi, Giuseppe 8; Rupoli, Serena 9; Cavazzini, Francesco 10; Martino, Bruno 11; Orlandi, Ester 12; Pregno, Patrizia 13; Annunziata, Mario 14; Usala, Emilio 15; Tiribelli, Mario 16; Sica, Simona 17; Bonifacio, Massimiliano 18; Fava, Carmen 19; Gherlinzoni, Filippo 20; Bocchia, Monica 21; Soverini, Simona 1; Bochicchio, Maria Teresa 1; Cavo, Michele 1; Giovanni, Martinelli 1; Saglio, Giuseppe 19; Pane, Fabrizio 22; Baccarani, Michele 23; Rosti, Gianantonio 1; on behalf of the GIMEMA CML Working Party
[Article]
American Journal Of Hematology.
92(8):797-805, August 2017.
(Format: HTML, PDF)